{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:56:00Z","timestamp":1771264560360,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3313-6","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T07:38:09Z","timestamp":1494574689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7862-3695","authenticated-orcid":false,"given":"Thilo","family":"Gambichler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Strutzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Tannapfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Susok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,12]]},"reference":[{"key":"3313_CR1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1067\/mjd.2002.120474","volume":"47","author":"E Poszepczynska-Guign\u00e9","year":"2002","unstructured":"Poszepczynska-Guign\u00e9 E, Viguier M, Chosidow O, et al. Paraneoplastic acral vascular syndrome: epidemiologic features, clinical manifestations, and disease sequelae. J Am Acad Dermatol. 2002;47:47\u201352.","journal-title":"J Am Acad Dermatol"},{"key":"3313_CR2","first-page":"82","volume":"14","author":"ST Hsu","year":"1996","unstructured":"Hsu ST, Lee YY, Lie MF. Symmetrical peripheral gangrene of sudden onset - a paraneoplastic syndrome? \u2013 a case report and review of the literature. Dematol Sinica. 1996;14:82\u20138.","journal-title":"Dematol Sinica"},{"key":"3313_CR3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/bmj.3.5559.208","volume":"3","author":"PR Hawley","year":"1967","unstructured":"Hawley PR, Johnston AW, Rankin JT. Association between digital ischaemia and malignant disease. Br Med J. 1967;3:208\u201312. 15","journal-title":"Br Med J"},{"key":"3313_CR4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00296-009-0985-5","volume":"30","author":"D Allen","year":"2010","unstructured":"Allen D, Robinson D, Mittoo S. Paraneoplastic Raynaud\u2019s phenomenon in a breast cancer survivor. Rheumatol Int. 2010;30:789\u201392.","journal-title":"Rheumatol Int"},{"key":"3313_CR5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0002-9343(92)90758-4","volume":"92","author":"AJ DeCross","year":"1992","unstructured":"DeCross AJ, Sahasrabudhe DM. Paraneoplastic Raynaud\u2019s phenomenon. Am J Med. 1992;92:571\u20132.","journal-title":"Am J Med"},{"key":"3313_CR6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00000658-198707000-00010","volume":"206","author":"LM Taylor Jr","year":"1987","unstructured":"Taylor LM Jr, Hauty MG, Edwards JM, et al. Digital ischemia as a manifestation of malignancy. Ann Surg. 1987;206:62\u20138.","journal-title":"Ann Surg"},{"issue":"7","key":"3313_CR7","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ad.2014.12.019","volume":"106","author":"AM Rodr\u00edguez Mart\u00edn","year":"2015","unstructured":"Rodr\u00edguez Mart\u00edn AM, Guirao Arrabal E, Jim\u00e9nez Puya R, V\u00e9lez Garc\u00eda-Nieto A. Paraneoplastic Acral Vascular Syndrome. Actas Dermosifiliogr. 2015 Sep;106(7):601\u20132.","journal-title":"Actas Dermosifiliogr"},{"issue":"10","key":"3313_CR8","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/MD.0000000000000047","volume":"93","author":"M Le Besnerais","year":"2014","unstructured":"Le Besnerais M, Miranda S, Cailleux N, Girszyn N, Marie I, L\u00e9vesque H, Benhamou Y. Digital ischemia associated with cancer: results from a cohort study. Medicine (Baltimore). 2014;93(10):e47.","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"3313_CR9","doi-asserted-by":"crossref","first-page":"e0160221","DOI":"10.1371\/journal.pone.0160221","volume":"11","author":"N Abdel-Wahab","year":"2016","unstructured":"Abdel-Wahab N, Shah M, Suarez-Almazor ME. Adverse events associated with immune checkpoint blockade in patients with cancer: a systematic review of case reports. PLoS One. 2016;11(7):e0160221.","journal-title":"PLoS One"},{"key":"3313_CR10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejca.2015.11.016","volume":"54","author":"JM Michot","year":"2016","unstructured":"Michot JM, Bigenwald C, Champiat S, Collins M, Carbonnel F, Postel-Vinay S, Berdelou A, Varga A, Bahleda R, Hollebecque A, Massard C, Fuerea A, Ribrag V, Gazzah A, Armand JP, Amellal N, Angevin E, Noel N, Boutros C, Mateus C, Robert C, Soria JC, Marabelle A, Lambotte O. Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur J Cancer. 2016;54:139\u201348.","journal-title":"Eur J Cancer"},{"issue":"6","key":"3313_CR11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMra1507638","volume":"375","author":"FM Wigley","year":"2016","unstructured":"Wigley FM, Flavahan NA. Raynaud's phenomenon. N Engl J Med. 2016;375(6):556\u201365.","journal-title":"N Engl J Med"},{"issue":"3","key":"3313_CR12","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/1042819021000055066","volume":"44","author":"H Al-Zahrani","year":"2003","unstructured":"Al-Zahrani H, Gupta V, Minden MD, Messner HA, Lipton JH. Vascular events associated with alpha interferon therapy. Leuk Lymphoma. 2003;44(3):471\u20135.","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"3313_CR13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jnci\/81.7.497","volume":"81","author":"HF Dvorak","year":"1989","unstructured":"Dvorak HF, Gresser I. Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice. J Natl Cancer Inst. 1989;81(7):497\u2013502.","journal-title":"J Natl Cancer Inst"},{"key":"3313_CR14","doi-asserted-by":"crossref","unstructured":"Yshii LM, Gebauer CM, Pignolet B, Maur\u00e9 E, Qu\u00e9riault C, Pierau M, Saito H, Suzuki N, Brunner-Weinzierl M, Bauer J, Liblau R. CTLA4 blockade elicits paraneoplastic neurological disease in a mouse model. Brain. 2016. [Epub ahead of print] PubMed PMID: 27604307.","DOI":"10.1093\/brain\/aww225"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3313-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T10:41:59Z","timestamp":1569321719000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3313-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,12]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3313"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3313-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,12]]},"article-number":"327"}}